These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 15898611

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Mesalazine is effective in Crohn disease 2].
    Quartarolo JP, Laegemidler F, Eskerod O.
    Ugeskr Laeger; 2005 Mar 14; 167(11):1308-9; author reply 1309. PubMed ID: 15830510
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Angioedema in Crohn's disease possibly due to mesalazine].
    Nguyen-Khac E, Le Baron F, Thevenot T, Tiry-Lescut C, Tiry F.
    Gastroenterol Clin Biol; 2002 May 14; 26(5):535-6. PubMed ID: 12122371
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Correction of mesalazine-induced neutropenia with high-dose G-CSF.
    Bhidayasiri R, Katz JA, Sokos DR.
    Am J Gastroenterol; 2000 Nov 14; 95(11):3321-2. PubMed ID: 11095375
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Improved treatment of Crohn's disease].
    Nau JY.
    Rev Med Suisse; 2005 May 04; 1(18):1241. PubMed ID: 15977716
    [No Abstract] [Full Text] [Related]

  • 11. Mesalazine-induced lupus.
    Timsit MA, Anglicheau D, Lioté F, Marteau P, Dryll A.
    Rev Rhum Engl Ed; 1997 Oct 04; 64(10):586-8. PubMed ID: 9385697
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Aminosalicylates for active disease and in the maintenance of remission in Crohn's disease.
    Feagan BG.
    Eur J Surg; 1998 Dec 04; 164(12):903-9. PubMed ID: 10029385
    [No Abstract] [Full Text] [Related]

  • 14. [Paradigmatic shift in drug treatment of Crohn disease].
    Munck LK.
    Ugeskr Laeger; 2005 Aug 15; 167(33):3013. PubMed ID: 16109239
    [No Abstract] [Full Text] [Related]

  • 15. Mesalazine as a maintenance treatment in Crohn's disease.
    Sutherland LR, Steinhart AH.
    Gut; 1998 Jan 15; 42(1):143-4. PubMed ID: 9505902
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inflammatory pseudotumor of the liver as the first manifestation of Crohn's disease.
    Amankonah TD, Strom CB, Vierling JM, Petrovic LM.
    Am J Gastroenterol; 2001 Aug 15; 96(8):2520-2. PubMed ID: 11513216
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.